Literature DB >> 15184606

Risk of Parkinson disease in women: effect of reproductive characteristics.

P Ragonese1, M D'Amelio, G Salemi, P Aridon, M Gammino, A Epifanio, L Morgante, G Savettieri.   

Abstract

OBJECTIVE: To investigate the association between some fertile life characteristics and Parkinson disease (PD) in women.
METHODS: Women affected by PD and control subjects were matched one to one by age (+/-2 years). One hundred thirty-one women with idiopathic PD and 131 matched control subjects were interviewed. Controls were randomly selected from the resident list of the same municipality of residence of cases. All subjects had a Mini-Mental State Examination score of > or =24. Cumulative length of pregnancies, age at menarche, age and type of menopause, and estrogen use before and after menopause were investigated in cases and controls through a structured questionnaire. Models of matched pair univariate analysis and conditional logistic regression analyses were used to calculate adjusted odds ratio (OR), 95% CI, and two-tailed p values for the investigated variables.
RESULTS: PD was significantly associated with a fertile life length shorter than 36 years (OR 2.07; 95% CI 1.00 to 4.30) and a cumulative length of pregnancies longer than 30 months (OR 2.19; 95% CI 1.22 to 3.91). An inverse association between PD and surgical menopause (adjusted OR 0.30; 95% CI 0.13 to 0.77) was also found.
CONCLUSIONS: An association between factors reducing estrogen stimulation during life and PD was found. These results support the hypothesis that endogenous estrogens play a role in the development of PD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184606     DOI: 10.1212/wnl.62.11.2010

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  52 in total

Review 1.  Parkinson's disease in women: a call for improved clinical studies and for comparative effectiveness research.

Authors:  J M Pavon; H E Whitson; M S Okun
Journal:  Maturitas       Date:  2010-02-01       Impact factor: 4.342

2.  Role of Apolipoprotein E, Cathepsin D, and Brain-Derived Neurotrophic Factor in Parkinson's Disease: A Study from Eastern India.

Authors:  Prosenjit Pal; Tamal Sadhukhan; Subhadip Chakraborty; Sriparna Sadhukhan; Arindam Biswas; Shyamal K Das; Kunal Ray; Jharna Ray
Journal:  Neuromolecular Med       Date:  2019-05-28       Impact factor: 3.843

Review 3.  Gender differences in neurological disease: role of estrogens and cytokines.

Authors:  Anna Członkowska; Agnieszka Ciesielska; Grazyna Gromadzka; Iwona Kurkowska-Jastrzebska
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

4.  Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease.

Authors:  Kelly Claire Simon; Honglei Chen; Xiang Gao; Michael A Schwarzschild; Alberto Ascherio
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

Review 5.  Genetics of iron regulation and the possible role of iron in Parkinson's disease.

Authors:  Shannon L Rhodes; Beate Ritz
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

6.  Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line.

Authors:  Shaletha Holmes; Meharvan Singh; Chang Su; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2016-05-11       Impact factor: 4.736

7.  Neuroprotective effect of exogenous melatonin on dopaminergic neurons of the substantia nigra in ovariectomized rats.

Authors:  Fereshteh Mehraein; Reza Talebi; Behnamedin Jameie; Mohammad Taghi Joghataie; Zahra Madjd
Journal:  Iran Biomed J       Date:  2011

8.  Female Sex and Brain-Selective Estrogen Benefit α-Synuclein Tetramerization and the PD-like Motor Syndrome in 3K Transgenic Mice.

Authors:  Molly M Rajsombath; Alice Y Nam; Maria Ericsson; Silke Nuber
Journal:  J Neurosci       Date:  2019-08-12       Impact factor: 6.167

9.  Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study.

Authors:  Louis C Tan; Woon-Puay Koh; Jian-Min Yuan; Renwei Wang; Wing-Lok Au; June H Tan; Eng-King Tan; Mimi C Yu
Journal:  Am J Epidemiol       Date:  2007-12-20       Impact factor: 4.897

10.  Risk of Parkinson's disease after tamoxifen treatment.

Authors:  Jeanne C Latourelle; Merete Dybdahl; Anita L Destefano; Richard H Myers; Timothy L Lash
Journal:  BMC Neurol       Date:  2010-04-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.